by Devac

On August 11, Russia announced the registration of the world’s first coronavirus vaccine, named “Sputnik V” by its developers at Gamaleya National Research Institute of Epidemiology. According to the terms of the drug’s registration, the vaccine’s developers must conduct large-scale “phase III” clinical trials on tens of thousands of volunteers. Meduza special correspondent Svetlana Reiter agreed to be one of these test subjects. We asked her to catalog the vaccine’s effects on her body and describe what it’s like to participate in such a momentous clinical study. Here is her diary.